Michael R. Hayden, Director at IONIS PHARMACEUTICALS INC (IONS), bought 7,500 shares at $36.23 ($272K) on 2024-12-23, disclosed to the SEC on 2024-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.20 | 2,500 | $91K | 33.3% |
| 2 | $36.23 | 2,500 | $91K | 33.3% |
| 3 | $36.23 | 2,500 | $91K | 33.3% |
| Total | $36.22 avg | 7,500 | $272K | 100% |
| Filing → |
| IONS | BUY | 2026-07-31 | $1.1M | — | Filing → |
| IONS | BUY | 2025-05-02 | $478K | — | Filing → |
| ABCL | BUY | 2023-09-26 | $98K | — | Filing → |